Condition: Myeloproliferative Neoplasm · Myeloproliferative Disorders · Sponsor: University Hospital, Bordeaux
Myeloproliferative neoplasms are hematologic diseases characterized by an increased proliferation of peripheral blood cells. The main risk of MPN is the occurrence of thrombosis. Thrombosis risk is mainly evaluated using two criteria: age and prior thrombosis. A better prediction of thrombosis risk is needed to improve prevention and treatment of MPN-associated thrombosis. The objective of the study is to evaluate the predictive value of neutrophil extracellular traps markers in thrombosis during MPN.
This description comes directly from the study's public registry record.
Alexandre GUY · 0557656478 · alexandre.guy@chu-bordeaux.fr
Chloé JAMES · 0557891979 · chloe.james@chu-bordeaux.fr
Always discuss trial participation with your own doctor first.
| CHU d'Angers, Service des maladies du Sang | Angers, France | Not Yet Recruiting |
| CH de la Côte Basque, Service Hématologie | Bayonne, France | Not Yet Recruiting |
| CHU de Bordeaux, Service Hématologie Biologique | Bordeaux, France | Not Yet Recruiting |
| CHU de Bordeaux, Service Hématologie Clinique et Thérapie Cellulaire | Bordeaux, France | Not Yet Recruiting |
| CHU de Brest, Service Hématologie et Hémostase Clinique | Brest, France | Not Yet Recruiting |
| APHP-Hôpital Mondor, Service Hématologie Clinique et Thérapie Cellulaire | Créteil, France | Not Yet Recruiting |
| CHD de Vendée, Service Onco-hématologie | La Roche-sur-Yon, France | Not Yet Recruiting |
| APHP-Hôpital Bicêtre, Service Hématologie Clinique Ambulatoire | Le Kremlin-Bicêtre, France | Not Yet Recruiting |
| CH de Libourne, Service Hématologie | Libourne, France | Recruiting |
| CHU de Limoges, Service Hématologie Clinique et de Thérapie Cellulaire | Limoges, France | Not Yet Recruiting |
| CH des Pays de Morlaix, Service Onco-Hématologie | Morlaix, France | Not Yet Recruiting |
| CHU de Nantes, Service Hématologie Clinique | Nantes, France | Not Yet Recruiting |
+ 3 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07119970